Yeastern Biotech Co., Ltd. is a Taiwanese private company located in Taipei that manufactures molecular biological reagents, health foods and cosmeceutical products.

Stratagene California is an American biotechnological company based in La Jolla, California, a maker of life science research and diagnostic products. It was established in 1984 and incorporated in California. It has been involved with the fields of cellular analysis, cloning, cytogenomics, DNA methylation and DNA Sizing and Quantification and food testing. In 2007, Agilent Technologies acquired Stratagene for $250 million, spinning off certain business assets and licensing certain molecular diagnostics technology to a new entity, Decisive Diagnostics. As of October 2011, the Chief Executive of the new company is Joseph Sorge, original founder and CEO of Stratagene.

Amgen Inc. (formerly Applied Molecular Genetics Inc.) is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. In 2018, the company's largest selling product lines were Neulasta, an immunostimulator used to prevent infections in patients undergoing cancer chemotherapy and Enbrel, a tumor necrosis factor blocker used in the treatment of rheumatoid arthritis and other autoimmune diseases. Other products include Epogen, Aranesp, Sensipar/Mimpara, Nplate, Vectibix, Prolia and XGEVA.

Sandoz AG, part of Novartis AG, is a company headquartered in Basel, Switzerland, that develops generic medicines and biosimilars.

Jiangsu Academy of Agricultural Sciences is a Chinese private company located in Nanjing, with subsidiaries in China, that engages in agriculture research and development.

Operates a biomedical group

Life-Tech, Inc. is a private company headquartered in Stafford, TX, with a presence in the United States, that manufactures and markets medical devices.

Life Technologies Corporation operates as a biotechnology tools company. The company's systems, consumables and services enable researchers to accelerate scientific exploration, to discoveries and developments. Life Technologies was created by the combination of [Invitrogen Corporation](/organization/invitrogen) and [Applied Biosystems, Inc.](/organization/applied-biosystems) in November of 2008, and Life Technologies continues to serve its customers under those two well-known brands. Invitrogen is the premier provider of reagents and consumables that are usable across multiple platforms, while Applied Biosystems remains the top provider of systems-based, end-to-end solutions in areas such as PCR, genetic sequencing, and mass spectrometry. The company delivers a range of products and services, including systems, instruments, reagents, and custom services. Its portfolio of products includes technologies for capillary electrophoresis based sequencing, sequencing, mass spectrometry, sample preparation, cell culture, RNA interference analysis, functional genomics research, proteomics and cell biology applications, as well as clinical diagnostic applications and water testing analysis.

MTI-GlobalStem has an active research program that utilizes expertise in transfection, neuroscience and stem cell biology to develop and supply scientists with the necessary tools and reagents to help advance new discoveries and developments in the life sciences. Utilizing our intellectual property and know-how, and a specialized team of highly skilled and experienced scientists, we are filling the gap with primary and iPSC-derived neural cells, stem cells and supporting feeder cells, optimized growth media and supplements, and an innovative platform of novel targeted reagents used to deliver nucleic acids into stem cells and neuronal cells with maximum efficiency.

The Institute Pasteur is a private, non-profit foundation. Its mission is to help prevent and treat diseases, mainly those of infectious origin, through research, teaching, and public health initiatives.The Institut Pasteur is a research center of international renown ideally located in the very heart of Paris. Each year the institute hosts a multitude of scientific and medical conferences and meetings as well as events on a variety of themes.

Tianjin Yaoyu Biotechnology Co., Ltd., established on 2009-06-05, Business scope includes research and development of biological products,Technology transfer and technical consulting services;medical instruments,drug development,technical consulting,transfer;biological reagent(food,except medicines)Wholesale and retail;account Serive;Timber wholesale and retail;Self-operated and agency goods import and export and technology import and export;Wholesale and retail of prepackaged food and bulk food.(If the above business scope involves industry licensing, the license certificate,Operate within the validity period,If the state has monopoly regulations, it shall be handled according to the regulations).

The Schepens Eye Research Institute, Inc. operates as an eye research institute. It offers treatment for macular degeneration, diabetic retinopathy, glaucoma, other types of retinal and optic nerve degenerations and damage, dry eye and eye tissue transplants. The company was founded by Charles L. Schepens in 1950 and is headquartered in Boston, MA.

Beijing Dingcheng Peptide Source Biotechnology Co., Ltd., established on 2014-03-26, Business scope includes biological,Pharmaceutical technology development,technology transfer,technical consulting,Technical Services;Sales of biological reagents(Free of Hazardous Chemicals,medicine).(Market entities independently choose business projects in accordance with the law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Anhui Universal Gene Technology Co., Ltd., established on 2018-04-20, The scope of business includes bioengineering, biomedical engineering and bioagricultural engineering,Technical services related to the field of bio-environmental protection,technology development,technology transfer,technical consulting,and related product development,design,to prepare,Production,Sales and after-sale technical service;Production of nucleic acid products;Sell ​​the company's self-produced products and carry out technical research and development of related biotechnology,technical consulting,Technical service and technology transfer and provision of after-sales service;body fluid,blood test;Medical testing consultation;Medical Information Consultation;Chemical testing;immunity,serum test;Microbial Detection;Cell molecular genetic testing service;Quality inspection technical service,technical consulting;Food Inspection and Testing;Research and development of food biotechnology;Food Technology Consulting Services;Agricultural product testing,environmental test,Water quality testing,soil testing,Biomaterial Testing Services;research and development,Production of chemical reagents,Biochemical reagents,biological reagent;Consumables,Small instruments and plastic products related to bioengineering,rubber products,glassware,Chemical Products(Free of Hazardous Chemicals),Enzyme,Equipment,instrument,Research and development of electronic products,Sales and technical service;Biomedical Technology and Software Technology Consulting,Serve,to develop,transfer;R&D of cosmetics,Sales;Class of medical equipment,Class II,Three types of sales;Self-operated or agent import and export business of various commodities(Except for commodities and technologies that are restricted and prohibited from import and export by the state).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Shanghai Medicilon, Inc. provides outsourced research and development services for pharmaceutical and biotechnology companies through contractual forms. Its business areas include Drug exploration and pharmaceutical research as well as Preclinical studies. Its services include chemistry services such as medical chemistry and synthetic chemistry, drug formulation, biology services such as computational biology and molecular modeling, pharmacology services such as transgenic mouse models and digestive system models, bioanalytical services, pharmacokinetic services, drug safety evaluation, and integrated projects such as chemical drug development and chemical compound druggability assessment. The company was founded by Jin Zhang Chen and Chun Lin Chen on February 2, 2004 and is headquartered in Shanghai, China.